相关实验视频
Updated: May 22, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.5K
针对胰岛素堆叠,以解决糖尿病患者住院患者的夜间低血糖症
Priyanka Moolchandani1,2, Satya Patel3,2, Tyler Larsen3,2
1Medicine, University of California Los Angeles, Los Angeles, California, USA pmoolchandani@mednet.ucla.edu.
BMJ open quality
|March 12, 2025
概括
降低糖尿病患者的夜间低血糖是非常重要的. 在入院患者中,延迟睡前胰岛素的服用显著降低了胰岛素堆积和随后的低血糖事件.
科学领域:
- 内部医学 内部医学
- 内分泌学 在内分泌学.
- 患者安全 患者安全
背景情况:
- 住院低血糖是糖尿病患者的严重并发症,与较高的死亡率有关.
- 胰岛素堆叠,定义为在4小时窗口内注射胰岛素剂量,有助于低血糖.
- 需要有效的策略来减轻与住院糖尿病管理相关的风险.
研究的目的:
- 为了减少住院糖尿病患者的夜间低血糖症.
- 为了解决和减少胰岛素堆叠的发生率.
- 改善医疗保健系统环境中的患者安全和结果.
主要方法:
- 在退伍军人事务大洛杉矶医疗保健系统实施了一个项目.
- 专注于修改胰岛素管理的电子健康记录协议.
- 特别针对睡前正胰岛素的时间,以防止堆叠.
主要成果:
- 在一年内,患者患上胰岛素堆叠的比例减少了28%.
- 在夜间低血糖事件中显著下降.
- 验证了延迟正胰岛素时间的有效性.
结论:
- 延迟睡前补丁胰岛素是减少胰岛素堆积的有效策略.
- 这种干预措施导致住院低血糖症的显著减少.
- 基于电子健康记录的干预措施可以改善糖尿病护理和患者安全.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
135
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
135
Hypoglycemia and Glucagon
146
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
146
Insulin Formulations: Types and Delivery
150
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
150
Oral Hypoglycemic Agents: Glinides
124
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
124
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.0K
Hormones Regulating Blood Glucose
3.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.0K

